Conocerlas para diagnosticarlas | 12 SEP 21

Formas de diabetes poco comunes

MODY, LADA, diabetes propensa a la cetosis y otras formas de diabetes.
Autor/a: Yun-Ni LeeA, Mohammed SB Hud Clinical Medicine 2021 Vol 21, N°4
INDICE:  1. Texto principal | 2. Referências bibliográficas
Referências bibliográficas

1 DiabetesUK. Diabetes statistics. Diabetes UK. www.diabetes.org.uk/ professionals/position-statements-reports/statistics [Accessed 11 May2020].

2 American Diabetes Association. Diagnosis and classification of dia­betes mellitus. Diabetes Care 2014;37(Suppl 1):81–90.

3 Shields BM, Hicks S, Shepherd MH et al. Maturity-onset diabetes of the young (MODY): How many cases are we missing? Diabetologia 2010;53:2504–8

4 Thanabalasingham G, Owen KR. Diagnosis and management of maturity onset diabetes of the young (MODY). BMJ 2011;343:d6044.

5 Stride A, Ellard S, Clark P et al. β-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1α mutation carriers. Diabetes Care 2005;28:1751–6.

6 Steele AM, Shields BM, Shepherd M et al. Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene. Diabet Med 2010;27:157–61.

7 Steele AM, Shields BM, Shepherd M et al. Microvascular complica­tion risk in patients with 50 years of moderate hyperglycemia: are target ranges for glycemia control appropriate? Diabet Med 2011;28(S1):2.

8 Steele AM, Shields BM, Wensley KJ et al. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA 2014;311:279–86.

9 Gupta RK, Vatamaniuk MZ, Lee CS et al. The MODY1 gene HNF-4α regulates selected genes involved in insulin secretion. J Clin Invest 2005;115:1006–15.

10 Besser REJ, Shepherd MH, McDonald TJ et al. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepato­cyte nuclear factor 1-α/hepatocyte nuclear factor 4-α maturity-onset diabetes of the young from long-duration type 1 diabetes. Diabetes Care 2011;34;286–91.

11 Naik RG, Brooks-Worrell BM, Palmer JP. Latent autoimmune dia­betes in adults. J Clin Endocrinol Metab 2009;94:4635–44.

12 Buzzetti R, Tuomi T, Mauricio D et al. Management of latent auto­immune diabetes in adults: A consensus statement from an inter­national expert panel. Diabetes 2020;69:2037–47.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

CONTENIDOS RELACIONADOS
AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024